Moderna, Pfizer & AstraZeneca seek urgent approval for their shots, just what Sputnik V was attacked for – don’t expect a backlash

Competitors

Competitors in the Covid-19 vaccine race are publishing clinical protocols in hopes of securing lucrative emergency approval, which Russia’s Sputnik V was previously attacked for seeking. This time, however, the media are quiet.

The frontrunners in the US and western Europe’s quest to develop a coronavirus vaccine – Pfizer, AstraZeneca, and Moderna – have published their trial protocols in response to growing public unease over the rapid rollout of the promised coronavirus magic bullet. They reveal an overwhelming emphasis on being first to secure emergency approval from the relevant regulators, suggesting the companies’ goal is maximum profits rather than ensuring the physical health of the hundreds of millions of people who will be expected to line up for vaccination.

Continue reading https://on.rt.com/aqz7